Ritsu Yamamoto
Overview
Explore the profile of Ritsu Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yamamoto R, Sakuragi N, Okamoto K
Nihon Rinsho
. 2004 Nov;
62 Suppl 10:169-74.
PMID: 15535227
No abstract available.
12.
Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, et al.
Gynecol Oncol
. 2004 Jul;
94(1):161-6.
PMID: 15262135
Objective: We evaluated the primary sites of lymph node (LN) metastasis in patients during the early stage of ovarian cancer. Methods: Study 1: patients with clinical stage I and II...
13.
Yamamoto R, Minobe S, Ebina Y, Watari H, Kudo M, Henmi F, et al.
Congenit Anom (Kyoto)
. 2004 Jun;
44(2):87-92.
PMID: 15198721
For the purpose of improving the clinical efficacy of alpha-fetoprotein (AFP)-L3% in prenatal screening for trisomy 21, we calculated the multiple of the median (MoM) of AFP-L3% (L3 MoM) and...
14.
Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, et al.
Biochem Biophys Res Commun
. 2004 Mar;
316(4):1156-62.
PMID: 15044106
We hypothesize that 14-3-3 sigma gene expression and its regulation by methylation can characterize histological types of primary human epithelial ovarian cancer. To test this hypothesis, ovarian cancer cell lines...
15.
Todo Y, Minobe S, Okamoto K, Takeda M, Ebina Y, Watari H, et al.
Jpn J Clin Oncol
. 2004 Feb;
33(12):636-41.
PMID: 14769842
Objective: Serous adenocarcinoma (SAC) of the endometrium has a poor prognosis compared with that of typical endometrioid adenocarcinoma (EAC). The objective of this study was to determine whether SAC can...
16.
Kaneuchi M, Sasaki M, Tanaka Y, Yamamoto R, Sakuragi N, Dahiya R
Int J Oncol
. 2003 Sep;
23(4):1167-72.
PMID: 12964000
Resveratrol and other polyphenols have anti-carcinogenic and anti-tumorigenic activities in various carcinomas. However, such studies are limited in endometrial cancer. We hypothesize that resveratrol suppresses cancer growth through modulation of...
17.
Yamamoto R, Ohkouchi T, Wakui Y, Minobe S, Watari H, Shimizu K, et al.
Acta Obstet Gynecol Scand
. 2003 Aug;
82(9):876-82.
PMID: 12911452
Background: It is generally believed that the lower the grade of differentiation of glycoprotein-producing cells, the more often modification by bisecting N-acetylglucosamine (GlcNAc) or fucose (Fuc) at the sugar chain...
18.
Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, et al.
Am J Obstet Gynecol
. 2003 May;
188(5):1265-72.
PMID: 12748496
Objective: The aim of this study was to predict retroperitoneal lymph node metastasis during the preoperative examination of patients with endometrial carcinoma and to determine whether lymphadenectomy must be performed....
19.
Todo Y, Sakuragi N, Oikawa M, Negishi H, Yamamoto R, Yoshiaki K, et al.
Int J Clin Oncol
. 2003 Apr;
8(2):90-6.
PMID: 12720101
Background: The survival effects of combined organ resection in cytoreductive surgery for advanced ovarian carcinoma with regard to the site and the number of organs involved have not yet been...
20.
Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, et al.
Acta Obstet Gynecol Scand
. 2003 Jan;
81(12):1144-51.
PMID: 12519111
Background: The aim of this study was to identify the independent histopathologic prognostic factors for patients with cervical carcinoma treated with radical hysterectomy including paraaortic lymphadenectomy. Methods: A total of...